s)/problem(s) faced by SSB by referring to the MFRS 137 Provisions, Contingent Liabilities and Contingent Assets

Financial Accounting
15th Edition
ISBN:9781337272124
Author:Carl Warren, James M. Reeve, Jonathan Duchac
Publisher:Carl Warren, James M. Reeve, Jonathan Duchac
Chapter1: Introduction To Accounting And Business
Section: Chapter Questions
Problem 26E
icon
Related questions
icon
Concept explainers
Topic Video
Question

Analyse the issue(s)/problem(s) faced by SSB by referring to the MFRS 137 Provisions, Contingent Liabilities and Contingent Assets

Suwit Semailee Berhad (SSB) is a manufacturer of branded and generic prescription
pharmaceuticals, vaccines and over-the-counter medications, based in Penang, Malaysia. The
company was established in 2000 and it is now in the process of business expansion pace. The
company closes its account on 31 March.
The following is the summary of SSB's statement of financial position as at 31 December 2021
(the third quarter of the accounting year):
quity and Liabilities
Assets
Plant (net)
Inventory
RM2,725,000 Share capital-ordinary
575,000 Retained earnings
550,000 Accounts payable
410,000
4,260,000
RM 2,000,000
1,885,000
375,000
Receivables
Cash
4,260,000
SSB is fighting a legal case with Boleh Jadi Berhad (BJB) for two years. There was a
transaction between both companies in 2019 where BJB was supposed to supply goods to SSB
for the return of RM600,000. The goods were delivered far behind the agreed date and some
of the goods had already expired. BJB offered to replace all the goods, but SSB did not agree
for replacement and denied payment to BJB. The case was filed in court by BJB demanded a
full payment and compensation of RM400,000 for the harassment. It has been two years and
the court will continue the hearing in February 2022. It seems that SBB is losing the case and
total payment of RM1,000,000 is to be made to BJB. Mr Aidil, the accountant of SSB Bhd is
not familiar with this event and not sure on how to account for the court case.
The company currently issued 800,000 ordinary shares. The management is planning to
distribute 20% share dividend as part of strategy to move its retained earnings to share capital.
Due to the need for business expansion, the management is also considering on the issuance of
more shares to induce the capital of the company. Among the options is issuing additional
200,000 ordinary shares at a price of RM2.75 per share. Another option is issuing 9%
preference shares, whether a non-cumulative or callable preference share. The CEO in the
earlier discussion with two of the directors showed more interest in issuing ordinary shares
rather than preference. However, the two directors had the opposing view due to certain
reasons.
On 1 January 2022, the company issued 100,000 ordinary shares at a price of RM2.75 per
share, for the exchange of herbal oil extraction machine worth RM290,000. Despite the
arguments on the types of shares to be issued, the company also on the same date, issued
300,000 ordinary shares for RM2.80 per share. The legal fees incurred in relation to the
issuance of the share were RM3,000.
The decisions on issuing ordinary shares were passed by a simple majority among board of
directors. The two directors involved in the initial discussions with the CEO are still not
satisfied with the decision. They plan to have another meeting with the CEO on the matters.
2
Transcribed Image Text:Suwit Semailee Berhad (SSB) is a manufacturer of branded and generic prescription pharmaceuticals, vaccines and over-the-counter medications, based in Penang, Malaysia. The company was established in 2000 and it is now in the process of business expansion pace. The company closes its account on 31 March. The following is the summary of SSB's statement of financial position as at 31 December 2021 (the third quarter of the accounting year): quity and Liabilities Assets Plant (net) Inventory RM2,725,000 Share capital-ordinary 575,000 Retained earnings 550,000 Accounts payable 410,000 4,260,000 RM 2,000,000 1,885,000 375,000 Receivables Cash 4,260,000 SSB is fighting a legal case with Boleh Jadi Berhad (BJB) for two years. There was a transaction between both companies in 2019 where BJB was supposed to supply goods to SSB for the return of RM600,000. The goods were delivered far behind the agreed date and some of the goods had already expired. BJB offered to replace all the goods, but SSB did not agree for replacement and denied payment to BJB. The case was filed in court by BJB demanded a full payment and compensation of RM400,000 for the harassment. It has been two years and the court will continue the hearing in February 2022. It seems that SBB is losing the case and total payment of RM1,000,000 is to be made to BJB. Mr Aidil, the accountant of SSB Bhd is not familiar with this event and not sure on how to account for the court case. The company currently issued 800,000 ordinary shares. The management is planning to distribute 20% share dividend as part of strategy to move its retained earnings to share capital. Due to the need for business expansion, the management is also considering on the issuance of more shares to induce the capital of the company. Among the options is issuing additional 200,000 ordinary shares at a price of RM2.75 per share. Another option is issuing 9% preference shares, whether a non-cumulative or callable preference share. The CEO in the earlier discussion with two of the directors showed more interest in issuing ordinary shares rather than preference. However, the two directors had the opposing view due to certain reasons. On 1 January 2022, the company issued 100,000 ordinary shares at a price of RM2.75 per share, for the exchange of herbal oil extraction machine worth RM290,000. Despite the arguments on the types of shares to be issued, the company also on the same date, issued 300,000 ordinary shares for RM2.80 per share. The legal fees incurred in relation to the issuance of the share were RM3,000. The decisions on issuing ordinary shares were passed by a simple majority among board of directors. The two directors involved in the initial discussions with the CEO are still not satisfied with the decision. They plan to have another meeting with the CEO on the matters. 2
Expert Solution
steps

Step by step

Solved in 2 steps

Blurred answer
Knowledge Booster
Financial Statements
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, accounting and related others by exploring similar questions and additional content below.
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
Financial Accounting
Financial Accounting
Accounting
ISBN:
9781337272124
Author:
Carl Warren, James M. Reeve, Jonathan Duchac
Publisher:
Cengage Learning
Financial Accounting
Financial Accounting
Accounting
ISBN:
9781305088436
Author:
Carl Warren, Jim Reeve, Jonathan Duchac
Publisher:
Cengage Learning